Black patients are underrepresented in clinical trials despite widespread efforts to increase minority participation.1,2 Eligibility criteria may disproportionately prevent black patients from participating due to racial variations in laboratory values. We studied this potential barrier by examining clinical trials in prostate cancer, a disease in which black men face higher incidence and mortality.3
Vastola ME, Yang DD, Muralidhar V, et al. Laboratory Eligibility Criteria as Potential Barriers to Participation by Black Men in Prostate Cancer Clinical Trials. JAMA Oncol. 2018;4(3):413–414. doi:10.1001/jamaoncol.2017.4658
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: